Research
-
GLP-1 Heart Failure Guidelines Changed in 2026
Europe's 2026 ESC guideline now says semaglutide or tirzepatide should be considered for a narrow group with symptomatic heart failure and obesity. It is an option for a cardiologist to weigh, not a direction to start either drug on your own.
-
How to Choose a Tirzepatide Provider: 7 Checks
Most of the difference between a careful service and a careless one shows up before a vial ever arrives — in who reads your history, who makes the medicine, and whether anyone answers afterwards.
-
Peptide Research 2026: What Three Reviews Found
Three review papers landed within a few weeks of each other this summer. They agree the animal work is real, the human evidence is thin, and that gap is the thing worth understanding.
-
503A Bulks List: What It Means
The 503A bulks list is a narrow ingredient pathway for patient-specific compounding. Here is how it differs from FDA categories, drug review and the separate 503B list.
-
Is BPC-157 FDA Approved? No—The Vote Was Advisory
BPC-157 is not FDA-approved, and no approved BPC-157 product exists anywhere. The July 2026 vote was advice on compounding, not drug approval.
-
Paradigm Peptides: A Lab Certificate Is Not Proof
The Paradigm Peptides sentencing exposed a simple weakness in buying medicine from an unlicensed website: a polished lab certificate can be fake. The safer difference is an accountable chain—a prescriber, a named pharmacy and records regulators can inspect.
-
No Shortcut: The Peptide FDA Approval Process
Mimrylo’s August 2026 approval is a useful look at the whole path: permission to begin human studies, three trial phases, a full application, manufacturing review, and a label limited to one use.
-
Retatrutide Lawsuit: It Is Still Investigational
Lilly sued six sellers in August, but the practical answer predates the cases: retatrutide remains investigational and no pharmacy can lawfully compound it for patients.
-
Compounded Tirzepatide Court Ruling Upholds FDA
The Fifth Circuit left FDA's tirzepatide shortage decision in place. That closes the broad shortage-era compounding route, but it does not erase the narrower rules for an identified patient.
-
The FDA Peptide Decision Hasn't Been Made Yet
An FDA advisory panel voted on seven peptides in July. Weeks on, nothing has been published — and that gap is the whole story.
-
FDA Peptide Warning Letters: What They Mean
FDA’s five August 24 letters targeted the way online sellers presented injectable peptides for people—not peptide molecules as a class. Here’s what changed, what didn’t, and how a prescription route differs.
-
What Are Peptides? A Plain-English Guide
Peptides are short chains of amino acids that the body uses as signals. The same broad family includes natural hormones, established medicines and experimental compounds, so the name alone says little about evidence or safety.
-
Are Peptides Legal in the US? What the Law Says
Prescription peptides can be lawful when a licensed provider prescribes them and an authorized pharmacy dispenses them under federal and state rules. A compounded medication, an approved drug and a grey-market vial do not share the same legal status.
-
Interstate Medical Licensure Compact Guide
The compact can speed a physician's path to licenses in multiple states, but each license still belongs to one state—and the patient's location still controls the telehealth check.
-
How to Check If a Telehealth Doctor Is Licensed
A license check takes only a few minutes when you use the right source. Start with the clinician's legal name, verify current authority in the state where you will attend the visit, and treat an NPI as a cross-check—not a license.
-
Are Peptides Safe? What the Risk Depends On
Safety is not a property a molecule carries on its own. It belongs to the compound plus a dose, plus the vial it came from, plus the person injecting it, plus someone qualified who is accountable for the decision.
-
How to Get Semaglutide Prescribed
You can get semaglutide through primary care, a specialist clinic, licensed telehealth or a manufacturer-supported route. Every legitimate path requires medical review before a pharmacy dispenses it.
-
Get Tirzepatide Online With a Prescription
Getting tirzepatide online still requires a prescription. The legitimate routes all end at the same checkpoint: an authorized clinician reviews your case before a licensed pharmacy dispenses anything.
-
How to Get Prescribed Peptides
The process is shorter than most people expect and has exactly one step that decides everything: a licensed provider reads your medical history and either writes the prescription or tells you no.
-
How to Reconstitute Peptides, Step by Step
What reconstitution involves, how the standard mixing technique works, and why your pharmacy's product-specific instructions govern every step.
Page 3 of 4 · 63 articles